EE107 Ponesimod Indicated for Patients With Active Relapsing Forms of Multiple Sclerosis: A Budget Impact Analysis From the Italian National and Regional Health Care Service Perspective
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.359
https://www.valueinhealthjournal.com/article/S1098-3015(22)02563-3/fulltext
Title :
EE107 Ponesimod Indicated for Patients With Active Relapsing Forms of Multiple Sclerosis: A Budget Impact Analysis From the Italian National and Regional Health Care Service Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02563-3&doi=10.1016/j.jval.2022.09.359
First page :
Section Title :
Open access? :
No
Section Order :
12167